IE
RLAY icon

Israel Englander’s Relay Therapeutics RLAY Stock Holding History

Israel Englander’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-190,000
Closed -$3.13M – 6601
2023
Q1 		$3.13M Buy
190,000
+135,800
+251% +$2.44M ﹤0.01% 3016
2022
Q4 		$810K Buy
+54,200
New +$1.04M ﹤0.01% 4362
2021
Q4 		– Sell
-10,000
Closed -$315K – 7298
2021
Q3 		$315K Buy
+10,000
New +$337K ﹤0.01% 5779

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Israel Englander's RLAY Position: Q2 2026 in Review

Israel Englander increased its Relay Therapeutics (RLAY) stake by 70% in Q2 2026, buying an estimated $3.54M and bringing the position to 591,675 shares worth $11.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2185.

Israel Englander first reported a position in RLAY in Q4 2020 and has held it in 21 quarters since. The position peaked at $19.8M in Q2 2023. 256 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Israel Englander held 591,675 shares of Relay Therapeutics worth $11.1M as of Q2 2026.
  • Israel Englander bought 243,942 Relay Therapeutics shares in Q2 2026, an estimated $3.54M.
  • Relay Therapeutics made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2185 holding.
  • Israel Englander first reported a position in Relay Therapeutics in Q4 2020 and has held it in 21 quarters since.
  • Israel Englander's Relay Therapeutics position peaked at $19.8M in Q2 2023.
  • 256 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.